Home » Health ARNA Panacea Ended ARNA Panacea ICO website Add to compare

ICO websiteWhite paper

ARNA Panacea ICO details Start Date: 2017-12-15 End date: 2018-2-10 Category: Health, Platform



Token: ARNA



Platform: Ethereum



Type: ERC20



Initial price: 1 ARNA = 0.08 USD



Bonus:



Accepting: ETH



Soft cap: 1,000,000 USD



Hard cap: 40,000,000 USD

ARNA Panacea

ARNA Genomics is an innovative biotechnological company, launched on the basis of the scientific and research laboratory and a team of like-minded people, engaged in development and research of early detection methods of oncological diseases with the purpose of launch of diagnostic tests for early cancer detection on the global market.

Our mission is to increase the life expectancy and significantly reduce human mortality by means of global market launch of most recent, unique in efficiency methods of screening (screening study with the purpose of detection and prevention of disease development in population), diagnostics (correct diagnosing) and monitoring of treatment process of oncological diseases.

ARNA Genomics company has discovered a technology which allows to develop tests for different types (nosologies) of cancer. Besides, the company has also developed a unique concept of blockchain based ecosystem, which will be used as an instrument to support R&D and implementation of biotechnologies worldwide.

We have completed R&D for the first product based on our technology – breast cancer test.

Colon cancer test is currently in R&D stage. Besides, we are currently developing a blockchain platform solution – ARNA Panacea, which will soon allow to change the world by making launch of new biotech solutions against cancer much easier and faster.

About ARNA Genomics

We are ARNA Genomics. We are an innovative biotechnological company, launched by a team of likeminded scientists and businessmen and grown from the scientific and research laboratory into full scale venture. We develop revolutionary early detection methods for select cancers in order to launch a line of diagnostic tests for early cancer detection on the global markets.

Our mission: to increase the life expectancy and significantly reduce human mortality. We relentlessly pursue this goal through cutting edge screening methods, diagnosis correction, treatment monitoring, and increasing patient adherence.

Our Innovation: ARNA Genomics has discovered a technology enabling highly specific tests development for different cancers. Besides, the company has also developed a unique concept of blockchain-based ecosystem-grade platform intended for use as an instrument to support R&D and implementation of biotechnologies worldwide.

Our Pledge: ARNA Genomics have completed R&D for its first product – ARNA Breast Cancer test.

The test for colon cancer test is currently in an advanced R&D stage. We devote all our resources to complete development of ARNA Panacea – a blockchain platform, that will hope will change the world by making launch of new biotech and treatment solutions against cancers much easier, cheaper and faster.

ARNA Panacea blockchain expert system



Key pain of modern healthcare is lack of trust between patients and healthcare system (Example – Homeopacy) Patients accuse healthcare major in selection bias that sabotages efficient inexpensive treatments ARNA Panacea blockchain will create expert system validating medical procedure results by the medical followup coming later All data will be fraud-proof, anonimous, transparent, and distributed Initially ARNA PANACEA will serve for validation of novel medical technologies later it will become the marketplace of healthcare attracting all players.

Why blockchain?

Blockchain can make analogues of real time processes, which allows:

to accelerate and to reduce the price of all processes;

to redistribute rewards for every participant of the process, based on the present market mechanisms, which creates a correct incentive system;

to make available and transparent as much as possible communication of all participants of the process from creation of biotechnological solution and its examination to commercialization, acceleration of market entry and availability to end consumers.

Set of these factors will impact the survival rate and human life expectancy.

Our solution of this problem is creation of an integrated ecosystem based on blockchain for conduction of all the stages, accompanying biotechnological products – from development to statistics and data collection – ARNA Panacea.

ARNA Panacea Platform



The system is expected to unite and serve the entire marketplace of global healthcare by providing multiple benefits to all stakeholders:

patients will be excited by the ability to observe and validate the constantly growing set of facts on the efficacy of diverse treatments

doctors will start using ARNA Panacea first as the storage of patient data and later as the tool to validate their own therapeutic successes

insurance companies will follow patients and doctors to employ ARNA Panacea in patient management

pharmaceutical companies will come to receive encrypted information about the modern state of the diseases and to recruit freshly diagnosed patients for all kind of research without revealing patient identity

regulators will come to use ARNA Panacea data to establish safety and efficacy of healthcare technologies

nvestors and scientists will join the community to exchange inventions and financing

Team

Egor Melnikov Founder of the project, CEO George Nikitin COO, co-founder and blockchain platform ideologist Dmitry Kulish Candidate of Biological Sciences Anatoliy Melnikov scientific supervisor and creator of the ARNA BC test Ilya Senechkin PhD, Wageningen University, Netherlands Sergey Chernyshev Ph.D., molecular biotechnologist Magomed Chatuev Software architect and developer Sergey Dolgachev Entrepreneur and co-owner

ARNA Panacea Advisors

Dmitry Grigoriev Sergey Borovskiy Marina Sekacheva Mikhail Groubman Larissa Belova Vladimir Savanovich Elkhan Sanay Ed Kanalosh

Milestones

2013 ARNA Genomics was established

2014 Seed round; Development of ARNA-Thermometr, a test for the presence of oncological diseases; “Know-how” objects formalization

2015 Development of ARNA Breast Cancer — a high-precision test for early detection of breast cancer

2016 Development of ARNA Colon Cancer; ARNA BC development is completed; Beginning of laboratory tests of ARNA BC; Submission of patent application No 1

2017 End of laboratory tests of ARNA BC; Start of ARNA BC clinical research jointly with Sechenov University; Submission of application of Patent Cooperation Treaty No 1; Token Distribution Event

2018 - Opening of the office and the 1st laboratory unit in the USA. - Submission of application of Patent Cooperation Treaty No 2 and 3. - Agreement of the regulatory strategy for ARNA BC. Launch of clinical research No 1 in the USA with FDA. - ARNA CC development is completed, starting laboratory research. - ARNA Panacea – launch of the beta version of blockchain-ecosystem, basic documentation for develop